I. Benattia - Concepedia

Author

I. Benattia

Emory University

Also Known As

Benattia, I., I Benattia, I. Benattia, Isma Benattia

Publications

Citations

H-Index

Concepts

All Affiliations

Emory University Duke University Hospital Duke Medical Center Pfizer (United States)University of Pittsburgh Medical Center

About

I. Benattia is an author at Emory University specializing in psychiatry, pharmacotherapy, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	510
2	Social Sciences	2	2	199
3	Business	1	1	12
4	Engineering	1	1	12
5	Management	1	1	12

I. Benattia

Publications

993

Citations

H-Index

Page 1

	Year	Citations
Treatment of Posttraumatic Stress Disorder With Venlafaxine Extended Release Jonathan Davidson, David S. Baldwin, Dan J. Stein, Archives of General Psychiatry	2006	226
Venlafaxine Extended Release in Posttraumatic Stress Disorder Jonathan Davidson, Barbara O. Rothbaum, Phebe Tucker, Journal of Clinical Psychopharmacology Week 12PsychoneuroimmunologyPsychiatryVenlafaxine Extended ReleasePsychotropic Medication	2006	156
Comprehensive Analysis of Remission (COMPARE) with Venlafaxine versus SSRIs Charles B. Nemeroff, Richard Entsuah, I. Benattia, Biological Psychiatry PsychiatryPsychotropic MedicationTreatment OptionPharmacotherapyComprehensive Analysis	2007	155
Comprehensive Analysis of Remission (COMPARE) with Venlafaxine versus SSRIs Charles B. Nemeroff, Richard Entsuah, I. Benattia, FOCUS The Journal of Lifelong Learning in Psychiatry Psychotropic MedicationPsychopharmacologyPharmacotherapyMental HealthSocial Sciences	2010	126
Venlafaxine Extended Release in the Short-Term Treatment of Depressed and Anxious Primary Care Patients With Multisomatoform Disorder Kurt Kroenke, Nicholas Messina, I. Benattia, The Journal of Clinical Psychiatry	2006	87
Efficacy and Tolerability of Ziprasidone Versus Risperidone in Patients With Acute Exacerbation of Schizophrenia or Schizoaffective Disorder Donald Addington, Christos Pantelis, Mary Dineen, The Journal of Clinical Psychiatry	2004	74
Ziprasidone and haloperidol in the treatment of acute exacerbation of schizophrenia and schizoaffective disorder: comparison of intramuscular and oral formulations in a 6-week, randomized, blinded-assessment study S. Brook, Jeorg Walden, I. Benattia, Psychopharmacology Oral FormulationsPsychiatryPsychotic DisorderPsychopharmacologySchizophrenia	2005	73
Effects of venlafaxine extended release on resilience in posttraumatic stress disorder: an item analysis of the Connor–Davidson Resilience Scale Jonathan Davidson, David S. Baldwin, Dan J. Stein, International Clinical Psychopharmacology	2008	49
The Patient’s Voice in Pharmacovigilance: Pragmatic Approaches to Building a Patient-Centric Drug Safety Organization Meredith Y. Smith, I. Benattia Drug Safety	2016	35
Structured Benefit-Risk Assessment Across the Product Lifecycle: Practical Considerations Meredith Y. Smith, I. Benattia, Carmit Strauss, Therapeutic Innovation & Regulatory Science EngineeringHealth EconomicsProduct LifecycleRisk ManagementManagement	2017	12

Page 1